Published in Lancet Infect Dis on February 01, 2010
Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA (2015) 2.53
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med (2011) 1.42
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ (2011) 1.26
Pneumonia in low and middle income countries: progress and challenges. Thorax (2013) 1.21
Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation (2011) 1.20
Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLoS One (2011) 1.17
Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis (2013) 1.06
The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One (2013) 0.96
Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links. Biomed Res Int (2014) 0.85
Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects. Epidemiol Infect (2013) 0.85
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia. Eur Respir J (2013) 0.84
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up. BMC Public Health (2012) 0.83
Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program. Chest (2011) 0.83
Pneumonia: an arrhythmogenic disease? Am J Med (2012) 0.83
Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart (2015) 0.82
Seasonal variations in cardiovascular disease. Nat Rev Cardiol (2017) 0.82
Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart (2016) 0.81
Hospitalized Infection as a Trigger for Acute Ischemic Stroke: The Atherosclerosis Risk in Communities Study. Stroke (2016) 0.80
Seasonal Influenza Infections and Cardiovascular Disease Mortality. JAMA Cardiol (2016) 0.80
Pneumolysin activates neutrophil extracellular trap formation. Clin Exp Immunol (2016) 0.79
Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure. PLoS One (2012) 0.78
Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol (2016) 0.78
The association of cardioprotective medications with pneumonia-related outcomes. PLoS One (2014) 0.77
Independent predictors of major adverse cardiovascular events in emergency department patients who are hospitalised with a suspected infection: a retrospective cohort study. BMJ Open (2016) 0.75
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia. ERJ Open Res (2015) 0.75
Puumala virus infections associated with cardiovascular causes of death. Emerg Infect Dis (2013) 0.75
The effect of community-acquired bacteraemia on return to workforce, risk of sick leave, permanent disability pension and death: a Danish population-based cohort study. BMJ Open (2014) 0.75
Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes: Results From a Prospective Cohort Study. Medicine (Baltimore) (2016) 0.75
In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil. Infect Drug Resist (2017) 0.75
Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events. Clin Infect Dis (2016) 0.75
The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial. Cardiol Res Pract (2016) 0.75
Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia. Pneumonia (Nathan) (2016) 0.75
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) (2003) 3.66
Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis (2009) 3.10
Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis (2005) 2.68
The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med (2007) 2.59
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) (2003) 2.51
Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis (2003) 2.50
Rickettsia sibirica infection in members of scientific expeditions to northern Asia. Lancet (2003) 2.20
Long-term survival following pneumococcal pneumonia. Clin Infect Dis (2013) 2.15
Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol (2006) 2.05
Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults? Clin Infect Dis (2012) 1.82
Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med (2002) 1.81
Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation (2003) 1.72
Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis (2009) 1.70
Secondary syphilitic lesions. Clin Microbiol Rev (2005) 1.64
Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review. J Infect (2011) 1.57
Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2006) 1.57
Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation (2012) 1.52
Pneumococcal vaccine--direct and indirect ("herd") effects. N Engl J Med (2006) 1.32
Acute pneumonia and the cardiovascular system. Lancet (2013) 1.25
Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm (2007) 1.18
Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol (2010) 1.17
Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia. J Infect (2009) 1.15
Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore) (2009) 1.14
pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis (2002) 1.08
Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med (2003) 1.06
A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus. Chest (2006) 1.05
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis (2003) 1.04
The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore) (2010) 1.03
Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA. J Infect (2008) 1.02
Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine (2009) 0.99
Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation (2003) 0.99
Telephone survey to assess influenza-like illness, United States, 2006. Emerg Infect Dis (2008) 0.95
Acute kidney injury associated with trimethoprim/sulfamethoxazole. J Antimicrob Chemother (2012) 0.95
The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis (2010) 0.95
Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis (2009) 0.94
Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci (2003) 0.93
Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria. J Infect Dis (2001) 0.93
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother (2004) 0.92
Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy (2007) 0.91
Community-Acquired Pneumonia Requiring Hospitalization. N Engl J Med (2015) 0.91
An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease. Gastroenterol Clin North Am (2006) 0.91
The incidence of necrotizing changes in adults with pneumococcal pneumonia. Clin Infect Dis (2011) 0.90
Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases. Circ Cardiovasc Qual Outcomes (2009) 0.89
Of birds and men: cardiologists' role in influenza pandemics. Lancet (2004) 0.88
Neurosyphilis: diagnosis and response to treatment. Clin Infect Dis (2008) 0.88
A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis (2009) 0.87
Genome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West Africa. PLoS One (2012) 0.87
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin. Scand J Infect Dis (2012) 0.87
Epidemic Clostridium difficile. N Engl J Med (2006) 0.87
The impact of statin and macrolide use on early survival in patients with pneumococcal pneumonia. Am J Med Sci (2013) 0.86
It's not that simple. Clin Infect Dis (2012) 0.86
Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques. Catheter Cardiovasc Interv (2003) 0.86
IRIS iQ200 workstation as a screen for performing urine culture. Diagn Microbiol Infect Dis (2012) 0.85
Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile. Clin Infect Dis (2002) 0.82
Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent. Future Microbiol (2007) 0.81
Clinical Diagnosis, Viral PCR, and Antibiotic Utilization in Community-Acquired Pneumonia. Am J Ther (2016) 0.80
Community-acquired pneumonia. N Engl J Med (2015) 0.80
Pneumococcal pyomyositis: report of 2 cases and review of the literature. Clin Infect Dis (2012) 0.79
The association between Staphylococcus aureus bacteremia and acute myocardial infarction. Scand J Infect Dis (2009) 0.79
Undisclosed conflicts of interest. Ann Intern Med (2006) 0.79
Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target. Future Cardiol (2009) 0.79
Severe pulmonary involvement in a case attributed to domestically acquired Seoul hantavirus in the United States. Clin Infect Dis (2011) 0.79
Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population. Scand J Infect Dis (2012) 0.79
The usefulness of sputum gram stain and culture. Arch Intern Med (2005) 0.79
Preventing myocardial infarction with vaccination: myths and realities. JAMA (2010) 0.78
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults? Australas Med J (2012) 0.78
Antibiotic stewardship and Clostridium difficile-associated disease. Infect Control Hosp Epidemiol (2008) 0.78
Plaque blush, branch location, and calcification are angiographic predictors of progression of mild to moderate coronary stenoses. Am Heart J (2003) 0.78
The long-term outcome of treatment of Clostridium difficile colitis. Clin Infect Dis (2007) 0.78
Clinical significance of Staphylococcus aureus bacteriuria at a tertiary care hospital. Scand J Infect Dis (2013) 0.78
Hypothermia is a bedside predictor of imminent death in patients with congestive heart failure. Am Heart J (2005) 0.77
The lack of therapeutic benefit of adding hydroxyurea to highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr (2002) 0.77
Computerized tomography (CT)-guided aspiration of abscesses: outcome of therapy at a tertiary care hospital. J Infect (2006) 0.77
Three-dimensional isotropic wavelets for post-acquisitional extraction of latent images of atherosclerotic plaque components from micro-computed tomography of human coronary arteries. Acad Radiol (2007) 0.77
Blood pressure measures and electrocardiogram-defined myocardial infarction in an Iranian population: Tehran Lipid and Glucose study. J Clin Hypertens (Greenwich) (2004) 0.76
Usefulness of multidetector computed tomography for noninvasive evaluation of coronary arteries in asymptomatic patients. Am J Cardiol (2005) 0.76
Quantification of roughness of calcific deposits in computed tomography scans of human coronary arteries. Invest Radiol (2007) 0.76
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force IV: cardiovascular effects of emerging infectious diseases and biological terrorism threats: basic, clinical, and population science research and training needs. J Am Coll Cardiol (2007) 0.76
Diagnosis of Clostridium difficile infection. Clin Infect Dis (2012) 0.75
The naming of strep, with apologies to T. S. Eliot. Clin Infect Dis (2009) 0.75
Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia. Clin Infect Dis (2011) 0.75
Ulceronodular syphilis (lues maligna praecox) in a person newly diagnosed with HIV infection. BMJ Case Rep (2011) 0.75
Diagnosis still in question. N Engl J Med (2002) 0.75
Dichotomy between content and interpretation. Clin Infect Dis (2009) 0.75
Anemia and infection. Clin Infect Dis (2004) 0.75
The open-artery hypothesis revisited. Tex Heart Inst J (2006) 0.75
Houston biosecurity: building a national model. Trans Am Clin Climatol Assoc (2004) 0.75
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 0.75
V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons. Clin Vaccine Immunol (2011) 0.75
Pneumococcal serotypes and virulence. J Infect Dis (2006) 0.75
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Circulation (2007) 0.75